Skip to main content
Premium Trial:

Request an Annual Quote

Cosmo Bio Distributing DNA2.0 Products in Japan

NEW YORK (GenomeWeb News) – DNA2.0 on Monday announced a deal with Cosmo Bio to distribute DNA2.0's complete line of bioengineering products.

Financial and other terms of the deal were not disclosed.

Customers can access DNA2.0's products directly, but the deal with Cosmo Bio provides customers in Japan added flexibility and time savings, as well as service and support, DNA2.0 said.

Based in Menlo Park, Calif., is a synthetic biology firm and the largest provider of synthetic genes in the US, it said. Cosmo Bio, based in Tokyo, provides life science products to researchers in Japan and elsewhere.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.